Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Hansson

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
JAMA Surgery|April 9, 2015
Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic CancerMarco Del Chiaro, Caroline S Verbeke, Nikolaos Kartalis, et al.
Cell Death and Differentiation|January 11, 2020
AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanomaIshani Das, Helge Gad, Lars Bräutigam, et al.
Journal of Translational Medicine|November 30, 2011
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanomaOmid Hamid, Henrik Schmidt, Aviram Nissan, et al.
Cancer Research|April 23, 2009
Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenograftsJessica Cedervall, Seema Jamil, Lina Prasmickaite, et al.
Melanoma Research|May 30, 2020
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenibLinda Vidarsdottir, Rita Valador Fernandes, Vasilios Zachariadis, et al.
Acta Dermato-Venereologica|September 28, 2020
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic MelanomaHanna Eriksson, Johan Hansson, Britta Krynitz, et al.
Cancer Immunology, Immunotherapy : CII|November 29, 2008
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanomaC Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, et al.
Lakartidningen|August 6, 2011
[Paradigmatic shift in oncology: individualized melanoma treatment]Johan Hansson, Eva Djureen-Mårtenson, Franziska Edvinsson, et al.
Frontiers in Oncology|March 3, 2020
Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant MelanomaSoudabeh Rad Pour, Hiromasa Morikawa, Narsis A Kiani, et al.
Oncotarget|April 21, 2017
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanomaYago Pico de Coaña, Maria Wolodarski, Isabel Poschke, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
JAMA Surgery|April 9, 2015
Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic CancerMarco Del Chiaro, Caroline S Verbeke, Nikolaos Kartalis, et al.
Cell Death and Differentiation|January 11, 2020
AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanomaIshani Das, Helge Gad, Lars Bräutigam, et al.
Journal of Translational Medicine|November 30, 2011
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanomaOmid Hamid, Henrik Schmidt, Aviram Nissan, et al.
Cancer Research|April 23, 2009
Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenograftsJessica Cedervall, Seema Jamil, Lina Prasmickaite, et al.
Melanoma Research|May 30, 2020
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenibLinda Vidarsdottir, Rita Valador Fernandes, Vasilios Zachariadis, et al.
Acta Dermato-Venereologica|September 28, 2020
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic MelanomaHanna Eriksson, Johan Hansson, Britta Krynitz, et al.
Cancer Immunology, Immunotherapy : CII|November 29, 2008
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanomaC Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, et al.
Lakartidningen|August 6, 2011
[Paradigmatic shift in oncology: individualized melanoma treatment]Johan Hansson, Eva Djureen-Mårtenson, Franziska Edvinsson, et al.
Frontiers in Oncology|March 3, 2020
Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant MelanomaSoudabeh Rad Pour, Hiromasa Morikawa, Narsis A Kiani, et al.
Oncotarget|April 21, 2017
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanomaYago Pico de Coaña, Maria Wolodarski, Isabel Poschke, et al.
Pageof 20